AssayIndex
Supplier scorecard

FGP — Flourishglobal Peptide Biotech (Chengdu) Co., Ltd.

Chengdu, CN · established 2019. The index holds 296 assay reports across 51 batches and 27 compounds, contributed by 6 laboratories. Every figure below is computed from those records and from nothing else.

296 reports51 batchesmedian purity 99.68 %documentation 90/100

Where FGP sells

Flourishglobal Peptide Biotech (Chengdu) Co., Ltd. sells from its own storefront. The link is marked nofollow and sponsored: it exists so the figures on this scorecard can be read against what the supplier itself publishes. The index is paid nothing for it and a link is not an assessment.

Visit FGP at flourishglobalpeptide.net →

Every figure above describes lots the index has seen. It says nothing about the lot you are offered, and the only check that does is the one on the certificate against the vial.

Block 1

Identification

Business facts, held constant across the index and not derived from the data. The index sells nothing and takes no supplier payment for placement; the storefront link below is marked nofollow and sponsored so a record can be checked against the seller, and is not a recommendation.

Legal name
Flourishglobal Peptide Biotech (Chengdu) Co., Ltd.
Short code in this index
FGP
Also known as
FGP · FGP Biotech · Flourishglobal Peptide Biotech (Chengdu)
City
Chengdu
Region
Chengdu
Country
CN
Established
2019
First record in index
16 Feb 2024
Most recent record
05 Oct 2026
/* >>> warehouse block >>> */
Block 1b

Dispatch and warehouses

Where the supplier holds regional stock. Material assayed by the index is dispatched from these locations, not from the manufacturing site.

  • Netherlands (Rotterdam) — European Union, 2-4 days
  • Germany (Hamburg) — Germany, Austria, Switzerland, 2-4 days
  • United Kingdom (London) — United Kingdom & Ireland, 2-3 days
  • United States (California) — United States, 2-4 days
  • Canada (Toronto) — Canada, 3-5 days
  • Australia (Melbourne) — Australia & New Zealand, 3-5 days
/* <<< warehouse block <<< */
Block 2

Headline statistics

Each figure carries the n it was computed from. The n= badge next to a statistic is the number of records it was computed from. Below n=8 the badge is amber. Below n=3 the statistic is suppressed and the individual values are shown instead.

Median purity 99.68% n=296
Interquartile range 0.68pp n=296
10th percentile 98.69% n=296
Pass rate vs index spec 98.6% n=296
Median recovery vs claim 98.2% n=169
Median water 4.69% n=296
Median |mass error| 2.4ppm n=247
Records carrying a flag 59.8% n=296
0377411192.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=096.75–97.00 %: n=197.00–97.25 %: n=097.25–97.50 %: n=397.50–97.75 %: n=497.75–98.00 %: n=298.00–98.25 %: n=598.25–98.50 %: n=798.50–98.75 %: n=1498.75–99.00 %: n=1499.00–99.25 %: n=2399.25–99.50 %: n=4499.50–99.75 %: n=4999.75–100.00 %: n=130median 99.68 Purity (% area) Reports
Figure 1. Purity distribution for all 296 FGP records carrying a purity figure. Domain fixed at 92–100 % area and bin width 0.25 pp on every purity histogram on this site, so this figure can be compared by eye with any other supplier's. Dashed line is the FGP median, 99.68 %; the index median is 98.99 %.
Block 3

Reproducibility across independent tests of one lot

Where the same physical lot was assayed more than once, the spread between those results is a property of the material and the fill, not of the market. It is the rarest and most informative statistic on this page, and it exists only for lots someone tested twice.

Median within-batch spread 0.59pp n=40
Index median spread 0.95pp n=20
Lots tested 3+ times 40 n=51

Across the 40 FGP lots in the index with three or more independent assays, the median spread between the highest and lowest purity result on one lot is 0.59 pp. Interpreting that number requires the laboratory repeatability figures: the best contributing laboratory here repeats to 0.16 pp and the worst to 0.34 pp, so a within-lot spread under about 0.5 pp is indistinguishable from measurement noise and a spread above 1 pp is a statement about the material.

Block 4

Supplier certificate against independent measurement

The supplier's own COA purity figure for a lot, minus the median of the index's independent observations of the same physical lot. Positive means the certificate reads higher than the measurement. Rule AX-R05 fires above 1.5 pp.

Median COA divergence +0.20pp n=51
Index median divergence +0.31pp n=20
Divergences in the supplier's favour 75% n=51
Divergences beyond 1 pp 2% n=51
Block 5

Provenance — where the tested material came from

Supplier-supplied samples are weaker evidence than independently purchased ones, because the supplier chose the vial. The index measures the size of that effect rather than assuming it.

Buyer-sourced median 99.33% n=24
Supplier-supplied median 99.72% n=254
Supplier-supplied share of records 85.8% n=296
96.697.297.898.499.099.6100.2Buyer-sourcedBuyer-sourced: Q1 99.08, median 99.33, Q3 99.66, n=24outlier 96.86outlier 97.67n=24Supplier-suppliedSupplier-supplied: Q1 99.30, median 99.72, Q3 99.93, n=254outlier 97.37outlier 97.48outlier 97.49outlier 97.58outlier 97.65outlier 97.70outlier 97.95outlier 98.01outlier 98.03outlier 98.07outlier 98.09outlier 98.11outlier 98.26outlier 98.27n=254Laboratory-retainedLaboratory-retained: Q1 99.05, median 99.25, Q3 99.67, n=18outlier 97.91n=18 Purity (% area)
Figure 2. FGP purity by sample provenance. Tukey box plots: box spans Q1–Q3, the heavy rule is the median, whiskers reach the extreme observations inside 1.5 IQR of the box, and points outside the fences are plotted individually. The vertical line is the FGP overall median. Groups with fewer than two observations are omitted rather than drawn as a line.
Block 6

Documentation completeness

The score is not an opinion about paperwork. Each component is the share of FGP batches in the index whose certificate carries that field, weighted as set out on the scoring rubric.

Documentation score 90/100 n=51
Index median score 79/100 n=20
Certificate fieldBatches carrying itRubric weight
Purity figure stated100%25 points
Analytical method stated (column, gradient, wavelength)80%25 points
Peptide content stated65%20 points
Endotoxin stated31%15 points
Named impurities rather than a total67%15 points
Block 7

Coverage by compound

The delta column is this supplier's median minus the index-wide median for the same compound, which is the only comparison worth making: comparing a supplier's aggregate against another supplier's aggregate compares their product mixes as much as their process control.

CompoundClassReportsMedian %Index median %Δ (pp)Index specPass %
TirzepatideIncretin2998.3798.44-0.0797.097
PT-141 (Bremelanotide)Melanocortin-receptor2899.9399.31+0.6298.5100
TB-500Tissue-repair2699.6899.47+0.2198.5100
SemaglutideIncretin2299.5998.87+0.7297.0100
BPC-157Tissue-repair2299.7599.15+0.6098.0100
GHRP-6Growth-hormone2099.8299.65+0.1799.095
IpamorelinGrowth-hormone1899.9099.48+0.4299.094
L-Glutathione (reduced)Short1899.8399.00+0.8398.5100
KPVTissue-repair1499.9399.21+0.7299.0100
CJC-1295 (no DAC)Growth-hormone1299.6198.61+1.0098.0100
SS-31 (Elamipretide)Metabolic1299.9399.42+0.5198.5100
SermorelinGrowth-hormone1099.3398.94+0.3998.0100
SelankNeuroactive999.9399.13+0.8099.0100
MK-677 (Ibutamoren mesylate)Non-peptide899.6199.37+0.2498.5100
RetatrutideIncretin898.6998.41+0.2896.5100
ExenatideIncretin898.9298.94-0.0298.088
MOTS-cMetabolic899.7399.18+0.5598.0100
L-CarnosineShort6 n=699.8899.07+0.8199.0100
CagrilintideIncretin4 n=498.7398.59+0.1496.5100
Thymosin α1Tissue-repair3 n=398.8999.11-0.2297.5100
LL-37Tissue-repair2 n=2n<398.6196.5100
N-Acetyl Semax AmideNeuroactive2 n=2n<399.2698.5100
NAD+Non-peptide2 n=2n<398.8897.0100
OxytocinHypothalamic2 n=2n<399.5798.5100
DihexaNeuroactive1 n=1n<399.8498.5100
LeuprolideHypothalamic1 n=1n<399.0198.5100
GonadorelinHypothalamic1 n=1n<399.2898.5100

Full per-compound breakdown with distributions and caveats →

96.697.297.898.499.099.6100.2TirzepatideTirzepatide: Q1 97.70, median 98.37, Q3 99.08, n=29n=29PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.47, median 99.93, Q3 99.93, n=28outlier 98.65n=28TB-500TB-500: Q1 99.38, median 99.68, Q3 99.93, n=26n=26SemaglutideSemaglutide: Q1 99.35, median 99.59, Q3 99.77, n=22outlier 98.65n=22BPC-157BPC-157: Q1 99.49, median 99.75, Q3 99.93, n=22n=22GHRP-6GHRP-6: Q1 99.31, median 99.82, Q3 99.93, n=20n=20IpamorelinIpamorelin: Q1 99.34, median 99.90, Q3 99.93, n=18n=18L-Glutathione (reduce…L-Glutathione (reduce…: Q1 99.58, median 99.83, Q3 99.92, n=18n=18KPVKPV: Q1 99.73, median 99.93, Q3 99.93, n=14outlier 99.33n=14CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 99.40, median 99.61, Q3 99.93, n=12n=12SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 99.85, median 99.93, Q3 99.93, n=12outlier 99.42outlier 99.54outlier 99.72n=12SermorelinSermorelin: Q1 99.12, median 99.33, Q3 99.61, n=10n=10SelankSelank: Q1 99.75, median 99.93, Q3 99.93, n=9n=9MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 99.41, median 99.61, Q3 99.87, n=8n=8 Purity (% area)
Figure 3. FGP purity by compound, for the 14 compounds with at least four FGP records. Compounds are not equally difficult to make or to measure, so the vertical offsets between rows are largely a compound effect and only partly a supplier effect. Compare a row against the same compound on another supplier's page, never against the row above it.
Block 8

Quarterly trend

Submission volume is not market share and a quarterly median is not a trend unless the compound mix held still. Both caveats apply to every row below.

Median purity by quarter

Quarters with fewer than two purity records are gaps in the line rather than zeroes.

Coverage growth

Records added per quarter. Growth here is index coverage, not supplier volume.

QuarterBatchesReportsMedian purityRangeFlagged
2024-Q111n<30
2024-Q221899.6398.95–99.9317
2024-Q363999.8098.94–99.9321
2024-Q452999.6798.97–99.9313
2025-Q162599.5598.49–99.9313
2025-Q264399.8597.91–99.9330
2025-Q361499.7099.07–99.932
2025-Q443599.6898.65–99.9319
2026-Q153599.8798.27–99.9323
2026-Q284499.4096.86–99.9329
2026-Q321399.2398.37–99.7910

Full quarterly timeline, batch by batch →

Block 9

Which laboratory produced these numbers

Laboratories disagree with each other by a measured amount. A supplier tested mostly by one laboratory carries that laboratory's offset in its aggregate, and the adjusted column removes it.

LaboratoryReportsMedian purityLab bias (pp)Bias-adjusted
Janoshik14499.66+0.0099.66
PeptideMeter5199.67-0.0599.72
Medutest3899.62+0.0899.54
VendorInvestigate2599.33-0.1199.44
Nordanalyt2099.82+0.0299.80
Kestrel1899.93+0.2499.69

Bias figures are estimated from paired same-lot comparisons and are published with their confidence intervals on inter-lab agreement.

Block 10

What this data does and does not show

Block 11

On-the-record reviews 26

Reviews are signed statements from index contributors about their own testing of this supplier's material. They are opinions attached to evidence, and they are not used in any statistic on this page.

93.0/ 100891 ratings across the index network
p.antonsen94/100

Vials wrapped individually, foam cut to fit, nothing loose in the box. Packing that has clearly been thought about.

e.castellanos90/100

Solid on the ipamorelin 5 mg. Purity where it should be, transit 3 days, paperwork in order.

v.novak90/100

Held locally in Australia, so the mazdutide 5 mg arrived on day 5 without an import step.

p.eriksen94/100

Their warehouse in Germany had the semaglutide 5 mg in stock and it shipped the same afternoon. Tracking never left the country.

j.lindqvist94/100

Dispatched from their warehouse in Canada rather than from the factory, so the GHK-Cu 50 mg was with me on day 4.

a.fontaine94/100

Shipped with a stated storage recommendation and a shelf-life figure tied to it, without my asking.

v.sorensen94/100

Certificate claimed 97.9% on lot FGP-26-903. PeptideMeter came back 98.0%. On an independent column that is as close to agreement as this gets.

t.teixeira94/100

VendorInvestigate has now seen 6 of their lots through me. Not one has come back outside spec.

b.perrin94/100

Cold pack was still hard on arrival in Minneapolis on day 5. My logger never went above 6°C across the whole run.

e.frisk90/100

Reliable on the general catalogue lines. Purity figures cluster tightly and the certificates match the lots.

ah.okwuosa94/100

5 lots logged now, purity 99.1 to 99.1%. A band that tight is worth more to me than one spectacular number.

d.karlsen94/100

Weighed 7 vials from the ipamorelin 5 mg order against label. Every one inside 2% of stated mass. Fill consistency is harder than purity and they have it.

r.lehtinen94/100

Reordered on the strength of the last one and got an identical result. Repeatability is the product.

b.wojcik94/100

Moved here after two bad lots elsewhere. 3 orders in and the PeptideMeter numbers have been flat every single time.

an.nascimento94/100

Stock said available, stock was available, and it shipped the same day. That sequence is not as common as it should be.

f.chukwu94/100

Asked a genuinely technical question about pre-dispatch storage and got a reply with numbers in it, inside 4 hours.

n.ekstrom90/100

Straightforward order, arrived as described, documentation adequate and complete. Nothing to add, which is the point.

no.ibarra90/100

Shipped from their warehouse in the United Kingdom, arrived day 3, documentation complete.

ru.kirchner94/100

Tenth order from them, all BPC-157 10 mg. Sent one vial from each to PeptideMeter and the whole set landed inside half a point of each other. That flatness is exactly what I pay for.

w.cardoso94/100

Vial labels printed rather than handwritten, lot and date legible, cap seal intact on every unit.

an.vasquez90/100

Third order and it went the same way as the first two. Predictable in the way you want a supplier to be.

h.coelho94/100

Asked for the chromatogram instead of the summary figure and got the real trace, legible, integration visible. They send it without hesitating.

z.villalobos90/100

Ordered LL-37 5 mg twice. Both vials reconstituted cleanly and both matched their certificates.

g.petrov94/100

Reconstituted the GHRP-2 5 mg and it went clear on contact — no haze, no floaters, no long swirl. Tells you the lyophilisation was done properly.

p.petrov94/100

Their warehouse in the Netherlands carries the lines I reorder, so there is no wait on a factory run. Day 3 every time.

b.ferreira90/100

Everything about the order was routine in the best sense — quoted 4 days, arrived in 4.

Block 12

Most recent records

The 25 most recently submitted FGP records. All 296 are listed on the full record listing.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041742TirzepatideFGP-2603-L9714Janoshik2026-Q399.372.43105.5Supplier-supplied1MARGINAL
AX-2026-041767SemaglutideFGP-2602-M1508PeptideMeter2026-Q398.652.54Supplier-supplied2FAIL
AX-2026-041741TirzepatideFGP-2603-L9714PeptideMeter2026-Q398.622.57Supplier-supplied1MARGINAL
AX-2026-041772SemaglutideFGP-2602-M1508Janoshik2026-Q399.793.03107.5Supplier-supplied0PASS
AX-2026-041770SemaglutideFGP-2602-M1508VendorInvestigate2026-Q399.331.4890.3Buyer-sourced1MARGINAL
AX-2026-041769SemaglutideFGP-2602-M1508Janoshik2026-Q399.132.5592.9Supplier-supplied1MARGINAL
AX-2026-041768SemaglutideFGP-2602-M1508Janoshik2026-Q398.852.2090.3Supplier-supplied1MARGINAL
AX-2026-041771SemaglutideFGP-2602-M1508Janoshik2026-Q399.412.31Supplier-supplied0PASS
AX-2026-041766SemaglutideFGP-2602-M1508VendorInvestigate2026-Q398.742.51Buyer-sourced2FAIL
AX-2026-041774SemaglutideFGP-2602-M1508Nordanalyt2026-Q399.232.4091.1Supplier-supplied1MARGINAL
AX-2026-041739TirzepatideFGP-2603-L9714Medutest2026-Q399.672.6491.1Supplier-supplied1MARGINAL
AX-2026-041740TirzepatideFGP-2603-L9714Nordanalyt2026-Q398.372.76Supplier-supplied1MARGINAL
AX-2026-041773SemaglutideFGP-2602-M1508Janoshik2026-Q399.622.50101.7Supplier-supplied0PASS
AX-2026-041807TirzepatideFGP-2605-R1831Janoshik2026-Q298.116.4796.6Supplier-supplied2MARGINAL
AX-2026-041804TirzepatideFGP-2605-R1831Janoshik2026-Q297.676.4792.2Buyer-sourced2MARGINAL
AX-2026-041760CJC-1295 (no DAC)FGP-2601-V1242PeptideMeter2026-Q299.936.10Laboratory-retained2MARGINAL
AX-2026-041829BPC-157FGP-2601-E2289Janoshik2026-Q299.933.61Supplier-supplied1MARGINAL
AX-2026-041764MK-677 (Ibutamoren mesylate)FGP-2604-K1470Janoshik2026-Q299.935.34Supplier-supplied1FAIL
AX-2026-041803TirzepatideFGP-2605-R1831PeptideMeter2026-Q298.266.01104.9Supplier-supplied2MARGINAL
AX-2026-041763CJC-1295 (no DAC)FGP-2601-V1242VendorInvestigate2026-Q299.935.48Buyer-sourced1MARGINAL
AX-2026-041817PT-141 (Bremelanotide)FGP-2602-Y1702Janoshik2026-Q299.794.1299.8Supplier-supplied0PASS
AX-2026-041816PT-141 (Bremelanotide)FGP-2602-Y1702PeptideMeter2026-Q299.934.5490.7Supplier-supplied0PASS
AX-2026-041819PT-141 (Bremelanotide)FGP-2602-Y1702Janoshik2026-Q299.934.1993.0Supplier-supplied0PASS
AX-2026-041745TB-500FGP-2512-Y9750PeptideMeter2026-Q299.933.89Supplier-supplied0PASS
AX-2026-041778SS-31 (Elamipretide)FGP-2601-R1916VendorInvestigate2026-Q299.424.0590.3Buyer-sourced0PASS